Cancer

Targeted BMI1 inhibition impairs tumor growth lung adenocarcinomas with low CEBPα Expression

August 3, 2016

Researchers at the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS), in collaboration with Harvard Stem Cell Institute (HSCI), have discovered a new way in which the development of lung cancer can be stopped. In a study published in Science Translational Medicine, the researchers found that inhibiting a protein called BMI1 impaired tumour growth in lung cancer.

The study was led by HSCI Principal Faculty member Daniel Tenen, MD, his associate Elena Levantini, PhD, and included first author Dr Kol Jia Yong, a former

Read more about Targeted BMI1 inhibition impairs tumor growth lung adenocarcinomas with low CEBPα Expression